Umberto Veronesi

Umberto Veronesi's AcademicInfluence.com Rankings

Umberto Veronesi

Medical

#1337

World Rank

#1663

Historical Rank

Oncology

#58

World Rank

#61

Historical Rank

medical Degrees

Umberto Veronesi

Philosophy

#4313

World Rank

#6786

Historical Rank

Logic

#1806

World Rank

#2649

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Umberto Veronesi's Degrees

Doctorate Medicine University of Milan

Why Is Umberto Veronesi Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Umberto Veronesi's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials (2005) (6940)
Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. (2002) (3814)
Tamoxifen for early breast cancer: an overview of the randomised trials (1998) (3764)
A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. (2003) (2009)
Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes (1997) (1934)
Combination chemotherapy as an adjuvant treatment in operable breast cancer. (1976) (1273)
Comparing Radical Mastectomy with Quadrantectomy, Axillary Dissection, and Radiotherapy in Patients with Small Cancers of the Breast (1981) (1228)
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. (2013) (989)
Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women (1998) (808)
Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. (1999) (785)
Overview of the main outcomes in breast-cancer prevention trials (2003) (771)
Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. (1993) (740)
Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. (2001) (710)
Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial. (2013) (659)
Breast cancer (1) (1992) (624)
Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. (1990) (614)
Inefficacy of immediate node dissection in stage 1 melanoma of the limbs. (1977) (607)
Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. (1995) (514)
Sentinel Lymph Node Biopsy in Breast Cancer: Ten-Year Results of a Randomized Controlled Study (2010) (495)
Breast conservation is the treatment of choice in small breast cancer: long-term results of a randomized trial. (1990) (492)
Breast conservation is a safe method in patients with small cancer of the breast. Long-term results of three randomised trials on 1,973 patients. (1995) (475)
The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients. (1994) (467)
Narrow excision (1-cm margin). A safe procedure for thin cutaneous melanoma. (1991) (465)
Patterns of relapse and survival following radical mastectomy. Analysis of 716 consecutive patients (1978) (457)
Proceedings of the Consensus Conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19–22, 2001, Philadelphia, Pennsylvania (2002) (437)
Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. (2006) (428)
Thin Stage I Primary Cutaneous Malignant Melanoma (1988) (419)
Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer. (1999) (414)
Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data (2013) (398)
Global cancer surgery: delivering safe, affordable, and timely cancer surgery. (2015) (383)
Oxford textbook of oncology (1996) (381)
Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities (1982) (379)
Quadrantectomy versus lumpectomy for small size breast cancer. (1990) (366)
Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. (1982) (361)
Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: Sentinel node vs Observation after axillary UltraSouND). (2012) (358)
Prognosis of Breast Cancer Patients after Mastectomy and Dissection of Internal Mammary Nodes (1985) (348)
European Code Against Cancer and scientific justification: third version (2003). (2003) (332)
The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-year results of a randomised trial. (1999) (331)
Conservative treatment of early breast cancer. Long-term results of 1232 cases treated with quadrantectomy, axillary dissection, and radiotherapy. (1990) (323)
Comparison of Halsted mastectomy with quadrantectomy, axillary dissection, and radiotherapy in early breast cancer: long-term results. (1986) (319)
Proceedings of the Consensus Conference on the Role of Sentinel Lymph Node Biopsy in Carcinoma of the Breast April 19–22, 2001, Philadelphia, PA, USA (2002) (311)
A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated. (2001) (304)
Ductal lavage for detection of cellular atypia in women at high risk for breast cancer. (2001) (281)
Breast cancer (2). (1992) (272)
N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid. (1993) (266)
p53 as an independent prognostic marker in lymph node-negative breast cancer patients. (1993) (263)
Radical mastectomy versus radical mastectomy plus internal mammary dissection. Five‐year results of an international cooperative study (1976) (248)
The CMF program for operable breast cancer with positive axillary nodes: Updated analysis on the disease‐free interval, site of relapse and drug tolerance (1977) (247)
Breast cancer (Third of three parts) (1992) (238)
Intraoperative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electrons (2010) (234)
Distribution of axillary node metastases by level of invasion. An analysis of 539 cases (1987) (233)
Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma (2001) (231)
Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer. (1998) (225)
Nipple sparing mastectomy with nipple areola intraoperative radiotherapy: one thousand and one cases of a five years experience at the European institute of oncology of Milan (EIO) (2009) (213)
Tamoxifen for the prevention of breast cancer: late results of the Italian Randomized Tamoxifen Prevention Trial among women with hysterectomy. (2007) (212)
Predicting the status of axillary sentinel lymph nodes in 4351 patients with invasive breast carcinoma treated in a single institution (2005) (211)
Five-year administration of fenretinide: pharmacokinetics and effects on plasma retinol concentrations. (1993) (206)
Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial (2005) (203)
Antibody-guided three-step therapy for high grade glioma with yttrium-90 biotin (1999) (203)
[Recommendations on cancer screening in the European Union]. (2001) (201)
Risk of Internal Mammary Lymph Node Metastases and Its Relevance on Prognosis of Breast Cancer Patients (1983) (200)
A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers. (2003) (196)
Adjuvant CMF in breast cancer: comparative 5-year results of 12 versus 6 cycles. (1983) (195)
Thin stage I primary cutaneous malignant melanoma. Comparison of excision with margins of 1 or 3 cm. (1988) (194)
Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancer. (2006) (191)
Sentinel node biopsy in breast cancer: early results in 953 patients with negative sentinel node biopsy and no axillary dissection. (2005) (187)
Reoperation for locally recurrent breast cancer in patients previously treated with conservative surgery (1999) (180)
Extent of metastatic axillary involvement in 1446 cases of breast cancer. (1990) (172)
Overview of the main outcomes in breast cancer prevention trials (2003) (170)
Radical mastectomy versus radical mastectomy plus internal mammary dissection. Ten year results of an international cooperative trial in breast cancer (1983) (169)
Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. (2003) (167)
Comparison of radioguided excision with wire localization of occult breast lesions (1999) (167)
Avoiding axillary dissection in breast cancer surgery: a randomized trial to assess the role of axillary radiotherapy. (2005) (162)
Breast phyllodes tumor: a review of literature and a single center retrospective series analysis. (2013) (159)
Conservation approaches for the management of stage I/II carcinoma of the breast: Milan Cancer Institute Trials (2004) (159)
Multimodal treatment for locally advanced breast cancer. Result of chemotherapy-radiotherapy versus chemotherapy-surgery. (1981) (158)
Sentinel lymph node biopsy as an indicator for axillary dissection in early breast cancer. (2001) (158)
Italian randomized trial among women with hysterectomy: tamoxifen and hormone-dependent breast cancer in high-risk women. (2003) (153)
A randomized trial of adjuvant chemotherapy and immunotherapy in cutaneous melanoma (1982) (151)
Full-Dose Intraoperative Radiotherapy With Electrons During Breast-Conserving Surgery: Experience With 590 Cases (2005) (151)
Tamoxifen for breast cancer among hysterectomised women (2002) (150)
Analysis of local and regional recurrences in breast cancer after conservative surgery. (2010) (149)
High-intensity focused ultrasound ablation: effective and safe therapy for solid tumors in difficult locations. (2010) (149)
Nipple-sparing mastectomy in association with intra operative radiotherapy (ELIOT): a new type of mastectomy for breast cancer treatment (2006) (148)
Nipple-sparing mastectomy: risk of nipple-areolar recurrences in a series of 579 cases (2009) (146)
Measuring progress against cancer in Europe: has the 15% decline targeted for 2000 come about? (2003) (145)
Intraoperative radiation therapy with electrons (ELIOT) in early-stage breast cancer. (2003) (141)
Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery. (2003) (136)
Sentinel Node Biopsy Is Not a Standard Procedure in Ductal Carcinoma In Situ of the Breast: The Experience of the European Institute of Oncology on 854 Patients in 10 Years (2008) (134)
Effect of Tamoxifen on Venous Thromboembolic Events in a Breast Cancer Prevention Trial (2005) (134)
A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases. (2007) (132)
Local control and survival in early breast cancer: the Milan trial. (1986) (129)
Prospects of chemoprevention of human cancers with the synthetic retinoid fenretinide. (1994) (129)
Breast cancer (2005) (126)
Polymorphism in the CYP2D6 tamoxifen-metabolizing gene influences clinical effect but not hot flashes: data from the Italian Tamoxifen Trial. (2006) (125)
Optimized sentinel node scintigraphy in breast cancer. (1998) (124)
Sentinel lymph node biopsy in pregnant patients with breast cancer (2009) (122)
The value of radiotherapy on metastatic internal mammary nodes in breast cancer. Results on a large series. (2008) (120)
Can fenretinide protect women against ovarian cancer? (1995) (116)
How do the ASTRO consensus statement guidelines for the application of accelerated partial breast irradiation fit intraoperative radiotherapy? A retrospective analysis of patients treated at the European Institute of Oncology. (2012) (116)
Biologic activity of tamoxifen at low doses in healthy women. (1998) (114)
Safety of the synthetic retinoid fenretinide: long-term results from a controlled clinical trial for the prevention of contralateral breast cancer. (2001) (113)
Intraoperative Radiation Therapy for Breast Cancer: Technical Notes (2003) (110)
A randomized trial of adjuvant chemotherapy and immunotherapy in cutaneous melanoma. (1982) (110)
Expression of p53, glutathione S-transferase-pi, and Bcl-2 proteins and benefit from adjuvant radiotherapy in breast cancer. (1997) (109)
Use of technetium-99m-labeled colloid albumin for preoperative and intraoperative localization of nonpalpable breast lesions. (2000) (109)
Conservation Surgery After Primary Chemotherapy in Large Carcinomas of the Breast (1993) (107)
Biologic and clinicopathologic factors as indicators of specific relapse types in node-negative breast cancer. (1995) (107)
Particle beam therapy (hadrontherapy): basis for interest and clinical experience. (1998) (105)
Are surgical adjuvant trials altering the course of breast cancer? (1978) (104)
Axillary metastases in breast cancer patients with negative sentinel nodes: a follow-up of 3548 cases. (2009) (98)
Conservative surgery in patients with multifocal/multicentric breast cancer (2009) (97)
Electropotential measurements as a new diagnostic modality for breast cancer (1998) (96)
Surgical technique of intraoperative radiotherapy in conservative treatment of limited-stage breast cancer. (2002) (95)
Effect of menstrual phase on surgical treatment of breast cancer (1994) (95)
Sentinel lymph node biopsy in male patients with early breast cancer. (2007) (94)
Multimodal treatment in operable breast cancer: five-year results of the CMF programme. (1981) (92)
Internal mammary node lymphoscintigraphy and biopsy in breast cancer. (2002) (90)
Risk factors associated with recurrence after nipple-sparing mastectomy for invasive and intraepithelial neoplasia. (2012) (89)
Early breast cancer: evaluation of the prognostic role of the site of the primary tumor. (1998) (89)
Stage migration after biopsy of internal mammary chain lymph nodes in breast cancer patients (2002) (88)
When mastectomy becomes inevitable: the nipple-sparing approach. (2005) (88)
European School of Oncology Advisory report to the European Commission for the "Europe Against Cancer Programme" European Code Against Cancer. (1995) (87)
Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast April 19 to 22, 2001, Philadelphia, Pennsylvania. (2002) (87)
Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer (2005) (87)
Sentinel Lymph Node Metastasis in Microinvasive Breast Cancer (2004) (86)
Role of positron emission tomography scanning in the management of lung nodules detected at baseline computed tomography screening. (2007) (85)
Effect of fenretinide on ovarian carcinoma occurrence. (2002) (85)
Soft tissue sarcoma of the breast after conservative surgery and irradiation for early mammary cancer. (1994) (83)
Breast cancer (3). (1992) (83)
The Nipple-Sparing Mastectomy: Early Results of a Feasibility Study of a New Application of Perioperative Radiotherapy (Eliot) in the Treatment of Breast Cancer When Mastectomy is Indicated (2003) (83)
Effect of tamoxifen on measurements of hemostasis in healthy women. (1996) (83)
Radioguided occult lesion localization (ROLL) in breast cancer: maximizing efficacy, minimizing mutilation. (2002) (82)
Accelerated partial breast irradiation with intraoperative electrons: using GEC-ESTRO recommendations as guidance for patient selection. (2013) (81)
Ten year results of a randomised trial comparing two conservative treatment strategies for small size breast cancer. (1998) (80)
Male breast cancer: a special therapeutic problem. Anything new? (Review). (2004) (79)
Conservation surgery after primary chemotherapy in large carcinomas of the breast. (1993) (79)
Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. (1983) (79)
Randomized trial of fenretinide (4‐HPR) to prevent recurrences, new localizations and carcinomas in patients operated on for oral leukoplakia: Long‐term results (2005) (78)
Fenretinide (4‐HPR) in chemoprevention of oral leukoplakia (1993) (78)
Radiation protection in radioguided surgery of breast cancer. (1999) (78)
Milestones in Breast Cancer Treatment (2015) (75)
The Pilot Trial on Intraoperative Radiotherapy with Electrons (ELIOT): Update on the Results (2005) (75)
Preliminary results of electron intraoperative therapy boost and hypofractionated external beam radiotherapy after breast-conserving surgery in premenopausal women. (2008) (75)
Extensive Frozen Section Examination of Axillary Sentinel Nodes to Determine Selective Axillary Dissection (2001) (74)
Radical mastectomy versus radical mastectomy plus internal mammary dissection. Ten year results of an international cooperative trial in breast cancer. (1984) (73)
Consensus conference on breast conservation. (2006) (73)
Cellular immunity to human breast carcinoma (1972) (73)
N-(4-hydroxyphenyl)retinamide: a potent inducer of apoptosis in human neuroblastoma cells. (1994) (72)
Conservative treatment of breast cancer: A trial in progress at the cancer institute of Milan (1977) (71)
Second Biopsy of Axillary Sentinel Lymph Node for Reappearing Breast Cancer After Previous Sentinel Lymph Node Biopsy (2005) (70)
Rethinking TNM: breast cancer TNM classification for treatment decision-making and research. (2006) (67)
Prognostic factors for metachronous contralateral breast cancer: A comparison of the linear Cox regression model and its artificial neural network extension (1997) (67)
Prognostic significance of number and level of axillary node metastases in breast cancer (1993) (67)
Breast cancer diagnosed during pregnancy and lactation: biological features and treatment options. (2005) (67)
Stage I Melanoma of the Limbs. Immediate versus Delayed Node Dissection (1980) (67)
Clinicopathologic characteristics of 143 patients with synchronous bilateral invasive breast carcinomas treated in a single institution (2004) (66)
Consequences of sentinel node in clinical decision making in breast cancer and prospects for future studies. (1998) (65)
Development of axillary surgery in breast cancer. (2005) (64)
Validation of p53 accumulation as a predictor of distant metastasis at 10 years of follow-up in 1400 node-negative breast cancers. (1996) (64)
Prognosis of breast cancer with axillary node metastases after surgical treatment only. (1987) (64)
Robotic Nipple-sparing Mastectomy and Immediate Breast Reconstruction With Implant: First Report of Surgical Technique. (2017) (63)
Plasma testosterone and prognosis of postmenopausal breast cancer patients. (2007) (62)
Repeating Conservative Surgery after Ipsilateral Breast Tumor Reappearance: Criteria for Selecting the Best Candidates (2012) (62)
Surgical technique of intraoperative radiation therapy with electrons (ELIOT) in breast cancer: a lesson learned by over 1000 procedures. (2006) (62)
Physical function of the upper limb after breast cancer surgery. Results from the SOUND (Sentinel node vs. Observation after axillary Ultra-souND) trial. (2016) (60)
Chemoprevention of breast cancer with retinoids. (1992) (58)
Can we avoid axillary dissection in the micrometastatic sentinel node in breast cancer? (2012) (58)
Prognostic factors in locally advanced noninflammatory breast cancer. Long-term results following primary chemotherapy (1990) (57)
Sentinel node localization in primary melanoma: preoperative dynamic lymphoscintigraphy, intraoperative gamma probe, and vital dye guidance. (2000) (57)
Enlarged mastectomy for breast cancer. Review of 1,213 cases. (1971) (56)
The sentinel node and breast cancer (1999) (56)
Breast cancer chemoprevention. (1992) (55)
Prognosis based on primary breast carcinoma instead of pathological nodal status. (1994) (55)
The value of staging laparotomy in non‐Hodgkin's lymphomas. (With emphasis on the histiocytic type) (1974) (53)
Proceeding of the consensus conference of the role of sentinel lymph node biopsy in carcinoma or the breast April 19-22, 2001, Philadelphia, PA, USA. (2002) (52)
Changes in biological markers after primary chemotherapy for breast cancers (1995) (52)
In vivo dosimetry using radiochromic films during intraoperative electron beam radiation therapy in early-stage breast cancer. (2003) (52)
Conservative mastectomy: extending the idea of breast conservation. (2012) (52)
Breast cancer: from “maximum tolerable” to “minimum effective” treatment (2012) (52)
S3-1: Update of International Breast Cancer Study Group Trial 23-01 To Compare Axillary Dissection Versus No Axillary Dissection in Patients with Clinically Node Negative Breast Cancer and Micrometastases in the Sentinel Node. (2011) (52)
Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase 3 equivalence trial. (2021) (52)
Proceedings of the consensus conference on breast conservation, April 28 to May 1, 2005, Milan, Italy (2006) (51)
[Conservative treatment of breast cancer]. (1985) (50)
Immunodetection of bone marrow micrometastases in breast carcinoma patients and its correlation with primary tumour prognostic features. (1994) (50)
Rethinking TNM: A Breast Cancer Classification to Guide to Treatment and Facilitate Research (2009) (49)
Caring About Women and Cancer (CAWAC): a European survey of the perspectives and experiences of women with female cancers. (1999) (48)
Nipple-sparing mastectomy—is it worth the risk? (2011) (48)
Real-time in vivo dosimetry using micro-MOSFET detectors during intraoperative electron beam radiation therapy in early-stage breast cancer. (2006) (48)
Breast cancer in women subsequent to cystic disease of the breast. (1968) (48)
Sentinel lymph node biopsy in multicentric breast cancer. The experience of the European Institute of Oncology. (2006) (48)
Proposal for a Clinical Classification of Liver Metastases (1982) (48)
Robotic Nipple-sparing Mastectomy and Immediate Breast Reconstruction With Implant: First Report of Surgical Technique. (2015) (47)
A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary (2006) (46)
Intraoperative electrons. (2005) (45)
Ductal lavage and the clinical management of women at high risk for breast carcinoma (2002) (45)
Axillary radiotherapy instead of axillary dissection: A randomized trial (2002) (44)
Intraoperative electron beam radiotherapy (ELIOT) to the breast: a need for a quality assurance programme. (2005) (44)
Florence statement on breast cancer, 1998 forging the way ahead for more research on and better care in breast cancer. (1999) (43)
Chemoprevention of breast cancer with fenretinide. (1996) (42)
Multimodal therapy with CMF in resectable breast cancer with positive axillary nodes: the Milan Institute experience. (1982) (42)
When can a second conservative approach be considered for ipsilateral breast tumour recurrence? (2007) (42)
The evolution of the conservative approach to breast cancer. (2007) (41)
Pathologic and biological prognostic factors of breast cancers in short- and long-term hormone replacement therapy users (2002) (41)
Chemoprevention Trial of Contralateral Breast Cancer with Fenretinide. Rationale, Design, Methodology, Organization, Data Management, Statistics and Accrual (1997) (41)
Axillary dissection can be avoided in selected breast cancer patients: analysis of 401 cases. (1996) (41)
Preliminary 3-year results of 12 versus 6 cycles of surgical adjuvant CMF in premenopausal breast cancer. (1979) (40)
Sentinel lymph node biopsy is feasible even after total mastectomy (2007) (39)
Intraoperative avidination for radionuclide treatment as a radiotherapy boost in breast cancer: results of a phase II study with 90Y-labeled biotin (2010) (38)
Positive axillary sentinel lymph node: is axillary dissection always necessary? (2011) (38)
When Sentinel Lymph Node is Intramammary (2008) (38)
Effect of tamoxifen and transdermal hormone replacement therapy on cardiovascular risk factors in a prevention trial. Italian Chemoprevention Group. (1998) (38)
Analysis of the presence of cutaneous and mucosal papillomavirus types in ductal lavage fluid, milk and colostrum to evaluate its role in breast carcinogenesis (2009) (38)
Conservative Treatment of Breast Cancer: Its Evolution (2005) (38)
[Intraoperative radiotherapy (IORT) in treatment of breast carcinoma--a new therapeutic alternative within the scope of breast-saving therapy? Current status and future prospects. Report of experiences from the European Institute of Oncology (EIO), Mailand]. (2001) (38)
Sentinel node biopsy in elderly breast cancer patients. (2004) (36)
Importance of the level of axillary involvement in relation to traditional variables in the prognosis of breast cancer. (1999) (35)
Unavoidable mastectomy for ipsilateral breast tumour recurrence after conservative surgery: patient outcome. (2009) (35)
Adenolymphoma of the lower lip. (1960) (35)
Innovation in early breast cancer surgery: radio-guided occult lesion localization and sentinel node biopsy. (2002) (34)
Some Observations on Cancer of the Breast in Mothers and Daughters (1957) (34)
Cell kinetics as a predictive factor in node-positive breast cancer treated with adjuvant hormone therapy. (1993) (34)
A new option for early breast cancer patients previously irradiated for Hodgkin's disease: intraoperative radiotherapy with electrons (ELIOT) (2005) (34)
Sentinel lymph node biopsy performed with local anesthesia in patients with early-stage breast carcinoma. (2002) (34)
Patterns of Relapse and Survival in Operable Breast Carcinoma with Positive and Negative Axillary Nodes (1978) (33)
Oophorectomy for advanced carcinoma of the breast. (1975) (33)
Results of a breast-cancer-surgery trial compared with observational data from routine practice (1996) (33)
Chemoprevention of Breast Cancer with Fenretinide (4-HPR): Study of Long-Term Visual and Ophthalmologic Tolerability (1996) (32)
Antibodies to BK virus structural and tumor antigens in human sera from normal persons and from patients with various diseases, including neoplasia (1976) (32)
Relationships between plasma insulin-like growth factor-I and insulin-like growth factor binding protein-3 and second breast cancer risk in a prevention trial of fenretinide. (2003) (31)
Is Electron Beam Intraoperative Radiotherapy (ELIOT) Safe in Pregnant Women with Early Breast Cancer? In Vivo Dosimetry to Assess Fetal Dose (2008) (31)
Controlled clinical trials with fenretinide in breast cancer, basal cell carcinoma and oral leukoplakia (1995) (31)
Comparative evaluation of three combination regimens for advanced malignant melanoma: results of an international cooperative study. (1976) (31)
Retinoids in Cancer Chemoprevention (1995) (30)
Preoperative approach to thyroid tumours by a two-dimensional pulsed echo technique. (1968) (30)
Is [18F] fluorodeoxyglucose uptake by the primary tumor a prognostic factor in breast cancer? (2013) (30)
Contralateral breast cancer after limited surgery plus radiotherapy of early mammary tumors. (1987) (30)
Full-dose intraoperative radiotherapy with electrons in breast surgery: broadening the indications. (2005) (30)
Retinoids in cancer chemoprevention. Clinical trials with the synthetic analogue fenretinide. (1995) (29)
HRT opposed to low-dose tamoxifen (HOT study): rationale and design. (2003) (29)
Staging the Axilla in Early Breast Cancer: Will Imaging Replace Surgery? (2015) (29)
Sentinel Lymph Node Biopsy in Multicentric Breast Cancer: Five-Year Results in a Large Series from a Single Institution (2011) (28)
Retinoids, breast cancer and NK cells. (1993) (28)
IART: intraoperative avidination for radionuclide treatment. A new way of partial breast irradiation. (2007) (28)
Unnecessary axillary node dissections in the sentinel lymph node era. (2007) (27)
Focalized intraoperative irradiation after conservative surgery for early-stage breast cancer (2001) (27)
A phase-III prevention trial of low-dose tamoxifen in postmenopausal hormone replacement therapy users: the HOT study. (2013) (27)
Ductal intraepithelial neoplasia: postsurgical outcome for 1,267 women cared for in one single institution over 10 years. (2009) (26)
Breast-conserving surgery in 201 very young patients (<35 years). (2010) (26)
Evaluation of resection margins after breast conservative surgery with monoclonal antibodies. (1991) (26)
Chemoprevention of breast cancer: The Italian experience (2000) (26)
The management of early breast cancer (1982) (25)
Plasma Retinol and Prognosis of Postmenopausal Breast Cancer Patients (2009) (25)
Synthetic retinoid fenretinide in breast cancer chemoprevention (2007) (25)
Extended mastectomy for cancer of the breast (1967) (25)
Suppression of telomerase activity as an indicator of drug-induced cytotoxicity against cancer cells: in vitro studies with fresh human tumor samples. (1999) (24)
Mastectomy without radiotherapy: outcome analysis after 10 years of follow-up in a single institution (2012) (24)
Sentinel-node biopsy in breast cancer (1997) (23)
Nonpalpable breast carcinomas: long-term evaluation of 1,258 cases. (2010) (23)
Breast conservation following neoadjuvant therapy for breast cancer in the modern era: Are we losing the opportunity? (2016) (23)
Ipsilateral breast tumor reappearance in patients treated with conservative surgery after primary chemotherapy. The role of surgical margins on outcome (2006) (23)
Combination chemotherapy with DTIC (NSC-45388) in advanced malignant melanoma, soft tissue sarcomas, and Hodgkin's disease. (1976) (23)
Breast cancer classification: time for a change. (2009) (23)
Need for global action for cancer control. (2008) (22)
Intraoperative Avidination for Radionuclide Therapy: A Prospective New Development to Accelerate Radiotherapy in Breast Cancer (2007) (22)
Primary chemotherapy in operable breast cancer with favorable prognostic factors: a pilot study evaluating the efficacy of a regimen with a low subjective toxic burden containing vinorelbine, 5-fluorouracil and folinic acid (FLN). (1999) (22)
How important is the assessment of resection margins in conservative surgery for breast cancer? (1994) (22)
Breast conservation: Current results and future perspectives at the European Institute of Oncology (2007) (22)
Fenretinide breast cancer prevention trial: drug and retinol plasma levels in relation to age and disease outcome. (2003) (22)
Sentinel node localization in primary melanoma: learning curve and results. (1999) (21)
Intraoperative radiotherapy: the debate continues. (2004) (21)
Fenretinide and risk reduction of second breast cancer (2007) (21)
Partial irradiation of the breast: Old challenges, new solutions. (2006) (20)
New trends in the treatment of malignant melanoma. (1978) (20)
Laparoscopy and laparotomy in staging Hodgkin's and non-Hodgkin's lymphoma. (1976) (20)
Influence of Margin Status on Outcomes in Lobular Carcinoma: Experience of the European Institute of Oncology (2011) (20)
Oncoplastic Principles in Breast Surgery (2007) (19)
A reappraisal of oophorectomy in carcinoma of the breast. (1987) (19)
Full-dose intra-operative radiotherapy with electrons (ELIOT) during breast-conserving surgery: experience with 1246 cases (2008) (19)
Breast cancer among HIV‐infected patients: The experience of the European Institute of Oncology (2005) (19)
Tamoxifen: an enduring star. (2007) (19)
Assessment of Pulmonary Fibrosis after Radiotherapy (RT) in Breast Conserving Surgery: Comparison between Conventional External Beam RT (EBRT) and Intraoperative RT with Electrons (ELIOT) (2011) (19)
Risk factors associated with recurrence after nipple-sparing mastectomy for invasive and intraepithelial neoplasia. (2012) (18)
Prognosis of malignant melanoma according to regional metastases. (1971) (18)
Radiation survey around a Liac mobile electron linear accelerator for intraoperative radiation therapy (2009) (18)
The TNM classification of breast cancer: need for change (2010) (18)
Breast cancer sugery: a century after Halsted (2005) (16)
Controlled Study with Imidazole Carboxamide (DTIC), DTIC + Bacillus Calmette-Guérin (BCG), and DTIC + Corynebacterium Parvum in Advanced Malignant Melanoma (1984) (16)
Caring about women and cancer (CAWAC): a European survey of the perspectives and experiences of women with female cancers (1999) (16)
Value of limited surgery for breast cancer. (1978) (16)
Long term survival analysis: breast cancer and age at diagnosis. (1990) (15)
Consensus Conference on Breast Conservation, Milan, Italy, April 28–May 1, 2005 (2006) (15)
Conservative treatment of breast cancer with the QU.A.RT. technique (1985) (15)
Proceedings of the consensus conference on breast conservation, Milan, Italy, April 28-May 1, 2005. (2006) (15)
Electron intraoperative treatment in patients with early-stage breast cancer: data update (2006) (15)
Long-term side effects and cosmetic outcome in a pool of breast cancer patients treated with intraoperative radiotherapy with electrons as sole treatment. (2012) (14)
The management of ductal intraepithelial neoplasia (DIN): open controversies and guidelines of the Istituto Europeo di Oncologia (IEO), Milan, Italy (2011) (14)
Rationale and indications for limited surgery in breast cancer: Current data (1987) (13)
Primary chemotherapy for resectable breast cancer. (1993) (13)
NIH consensus meeting on early breast cancer. (1990) (13)
Progress and Perspectives in Chemoprevention of Cancer (1992) (13)
Sentinel node localisation: A new prospective in the treatment of nodal melanoma metastases. (1999) (13)
Local therapy for breast cancer in malignant lymphoma survivors. (2011) (12)
Chemoprevention: from research to clinical oncology. (2005) (12)
Intraoperative Radiotherapy during Breast Conserving Surgery in Patients Previously Treated with Radiotherapy for Hodgkin's Disease (2004) (12)
Atypia and Ki-67 Expression from Ductal Lavage in Women at Different Risk for Breast Cancer (2006) (12)
The Effects of a Nitrogen mustard Derivative of Phenylalanine on Experimental Tumours (1956) (12)
Expression of p 53 , Glutathione S-Transferase-p , and Bcl-2 Proteins and Benefit From Adjuvant Radiotherapy in Breast Cancer (1997) (12)
Retinoids for ovarian cancer prevention: laboratory data set the stage for thoughtful clinical trials. (2001) (12)
Conservative methods for breast cancer of small size: the experience of the National Cancer Institute, Milan (1973-1998). (1999) (12)
Cutaneous melanoma : status of knowledge and future perspective (1987) (11)
Timing of breast cancer surgery in relation to the menstrual cycle: an update of developments. (2001) (11)
Trials of adjuvant chemotherapy in breast cancer. The experience of the Istituto Nazionale Tumori of Milan. (1980) (11)
Mammographic patterns in breast cancer chemoprevention with fenretinide (4-HPR). (1993) (11)
Surgical approach to internal mammary lymph node biopsy. (2001) (11)
Controlled study for prolonged chemotherapy, immunotherapy, and chemotherapy plus immunotherapy as an adjuvant to surgery in malignant melanoma (Trial 6): preliminary report. (1978) (11)
Drop-outs in tamoxifen prevention trials (1999) (11)
Classification and Treatment of Hodgkin's Disease (1965) (11)
Analysis of the presence of cutaneous and mucosal papillomavirus types in ductal lavage fluid, milk and colostrum to evaluate its role in breast carcinogenesis (2009) (10)
Lessons from the initial adjuvant cyclophosphamide, methotrexate, and fluorouracil studies in operable breast cancer. (2008) (10)
Breast conservative surgery for well-differentiated ductal intraepithelial neoplasia: Risk factors for ipsilateral breast tumor recurrence. (2014) (10)
Adjuvant combination chemotherapy for operable breast cancer. Trials in progress at the Istituto Nazionale Tumori of Milan. (1981) (10)
Preserving life and conserving the breast. (2009) (10)
Conservative treatment of breast cancer: a trial in progress at the Cancer Institute of Milan. (1977) (10)
Indirect lymphography of the breast with iotasul: a vanishing hope? (1984) (10)
Preoperative Chemotherapy Alone and Combined with Preoperative Radiotherapy in Small‐Size Breast Cancer (1996) (10)
Surgical pitfalls after preoperative chemotherapy in large size breast cancer. (1994) (10)
Staging laparotomy in non-Hodgkin's lymphomata. (1975) (10)
The role of surgery in the management of primary breast cancer (1982) (10)
Is avoiding post-mastectomy radiotherapy justified for patients with four or more involved axillary nodes and endocrine-responsive tumours? Lessons from a series in a single institution. (2007) (9)
Present and future of sentinel node lymphadenectomy in breast cancer. (2000) (9)
[PROPOSAL OF CLASSIFICATION AND THERAPY OF HODGKIN'S DISEASE]. (1965) (9)
[Heredity of neoplasms in man. II. Breast cancer]. (1954) (9)
Lymphangiography in the diagnosis of retroperitoneal node metastases in rectal cancer. (1967) (9)
Clinical Staging and Treatment of Lymphosarcoma and Reticulum Cell Sarcoma. (1965) (9)
Two-dimensional ultrasounds in liver diseases. (1968) (9)
Linking survival of HER2-positive breast carcinoma patients with surgical invasiveness. (2006) (9)
Human transplacental passage of the retinoid fenretinide (4HPR) (1998) (8)
Prevention of breast cancer with tamoxifen: the Italian study in hysterectomized women (1995) (8)
Effect of Actinomycin M upon Mitosis (1957) (8)
Breast Cancer: Innovations in Research and Management (2020) (8)
The Lynn Sage Memorial Lecture: new developments in breast cancer management. (2001) (8)
Lymphatic Metastasis and Sentinel Lymphonodectomy (2012) (8)
Delayed node dissection in stage one malignant melanoma: justification and advantages. (1987) (8)
Lymphocyte toxicity test in clinical melanoma. (1973) (8)
No more axillary dissection in patients with ductal intraepithelial neoplasia (DIN). (2010) (8)
Long-term results of radical mastectomy with removal of internal mammary chain. (1959) (7)
Preliminary-results of preoperative axillary radioimmunoscintigraphy with in-111 b72.3 in breast-cancer. (1995) (7)
Accrual Issues for Chemoprevention Trials: The Example of the 4-HPR Study for the Prevention of Contralateral Breast Cancer (1999) (7)
Intravenous Administration of BCG in Advanced Melanoma Patients (1978) (7)
New trends in the treatment of breast cancer at the Cancer Institute of Milan. (1977) (7)
Grand Challenges in Surgical Oncology (2012) (7)
The quadrantectomy, axillary dissection and radiotherapy (QU.A.RT) technique in early breast cancer. (1983) (7)
Low dose spiral computed tomography for early diagnosis of lung cancer. Results of baseline screening in 5,000 high-risk volunteers. (2006) (7)
Conservative treatment for breast cancer of limited extent. Results of a randomized trial. (1981) (7)
Re: Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer. (2001) (7)
Cancer epidemiology, environmental factors (1975) (7)
Chemoprevention of Contralateral Breast Cancer with the Synthetic Retinoid Fenretinide (1988) (6)
Conservative treatment of breast cancer with QU.A.R.T. Technique. (1985) (6)
[Morphology and histogenesis of glomic tumors based on 8 personal case reports]. (1954) (6)
The role of heuristics and biases in cancer-related decisions (2013) (6)
Adjuvant combination chemotherapy in primary mammary carcinoma: the CMF program. (1977) (6)
New technologies for diagnosis and treatment of breast cancer: meeting highlights from the Fourth Milan Breast Cancer Conference (Milan, June 5-7, 2002). (2003) (6)
Current Trends in the Oncologic and Surgical Managements of Breast Cancer in Women with Implants: Incidence, Diagnosis, and Treatment. (2016) (5)
The hormone replacement therapy opposed to low dose tamoxifen (HOT) study: safety data from an ongoing phase III trial (2007) (5)
Intraoperative radiotherapy with electrons (ELIOT) for early breast cancer: the European Institute of Oncology experience (2014) (5)
Solitary Plasmocytoma of the Thyroid (1966) (5)
Oophorectomy for Advanced Breast Cancer (1966) (5)
A New TNM Classification for Breast Cancer to Meet the Demands of the Present and the Challenges of the Future (2011) (5)
[Hereditary problems of the cancer in man. I. General aspects]. (1954) (5)
New Approaches in Cancer Pharmacology: Drug Design and Development (1994) (5)
Rationale for a study adding tamoxifen to HRT. (2002) (5)
Surgical treatment of primary breast cancer. (1977) (5)
[PAPILLIFEROUS CARCINOMA APPEARING ON A CYST OF THE THYROGLOSSAL DUCT]. (1964) (5)
[Solitary plasmocytoma of the thyroid gland]. (1966) (5)
Chronic oral administration of fenretinide, as a chemopreventive agent to breast cancer patients, does not affect plasma alpha-tocopherol concentration. (1991) (5)
Can Axillary and Supraclavicular Radiotherapy be Avoided after Breast-Conserving Surgery and Axillary Dissection in Women with Multiple Involved Axillary Nodes?: Experience at the European Institute of Oncology (2008) (4)
Intranodular Treatment with BCG of Cutaneous and Subcutaneous Metastases of Malignant Melanoma. (1974) (4)
The influential and inspirational Gianni Bonadonna's life commitment to evidence-based cancer medicine. (2016) (4)
[Ovariectomy in the therapy of advanced carcinoma of the breast]. (1966) (4)
CMF adjuvant programs at the Milan Cancer Institute. (1984) (4)
[Proposal of classification and therapeutic criteria of lymphosarcoma and reticulosarcoma]. (1965) (4)
The Italian Tamoxifen Prevention Trial (2002) (4)
Regional lymph node dissection in melanoma of the limbs. Stage I. A cooperative international trial (WHO Collaborating Centers for diagnosis and treatment of melanoma). (1977) (4)
Papillary Carcinoma of the Thyroglossal Duct (1964) (4)
Surgical treatment of malignant melanoma of the skin (1979) (4)
Are All Patients with Ductal Carcinoma In Situ of the Breast Candidates for Radiotherapy after Breast Conservative Treatment? Institute of European Oncology Guidelines (2014) (4)
The nipple sparing mastectomy: a 5-year experience at the European Institute of Oncology of Milan (2007) (4)
[Malignant tumors in children]. (1952) (4)
Clinical management of minimal breast cancer. (1989) (4)
Margins of of resection of malignant melanomas that are less than the hitherto conventional "wide and deep" margins are not advisable as yet. (1985) (4)
Giant arteriovenous fistula in thyroid tumour inducing cardiac failure--selective angiography. (1972) (4)
Adriamycin (ADM) plus bleomycin (BLM) versus CTX plus VCR in advanced carcinoma of the cervix (1974) (4)
Xeroradiography of soft tissue tumors. (1981) (4)
Surgical aspects of the conservative treatment of large size breast cancer after primary chemotherapy (1993) (3)
Non palpable breast lesions: Analysis of 952 operated cases (1993) (3)
Adriamycin in Combination and in Combined Treatment Modalities. (1974) (3)
Cervical Metastases as First Symptom of Thyroid Cancer (1964) (3)
Long-Term Side Effects and Cosmetic Outcome in a Pool of Breast Cancer Patients Treated with Intraoperative Radiotherapy with Electrons as Sole Treatment (2012) (3)
[Carcinoma of the breast in childhood]. (1968) (3)
Digestive Tract Tumors (1986) (3)
Early detection of cancer: ideas for a debate. (2007) (3)
Chemoprevention of breast cancer. (1994) (3)
Re: Trends in the treatment of ductal carcinoma in situ of the breast. (2004) (3)
Breast cancer – Authors' reply (2005) (3)
The state of the preoperative diagnosis of breast cancer today. (1997) (3)
Prognostic Factors in Malignant Melanoma (1966) (3)
REMOVAL OF INTERNAL MAMMARY NODES IN CANCER OF THE BREAST: REPORT OF 350 CASES. (1963) (3)
[Conservative treatment of breast cancer. A therapeutic trial in progress at the Cancer Institute of Milan]. (1977) (3)
Long Term Results of Randomized Trial Comparing Immediate Versus Delayed Node Dissection in Stage I Melanoma of the Limbs (1984) (3)
The Current Status of Breast‐Conserving Therapy (1996) (3)
Results of Chemotherapy in Breast Cancer. Study Group for Therapy of Breast Cancer, Cancer Chemotherapy Committee, Italian Society of Cancerology (1968) (3)
Adjuvant combination chemotherapy with CMF in primary mammary carcinoma (1977) (3)
Controlled study with multiple drug combination in advanced breast cancer (1974) (3)
BIOLOGIC AND CLINICOPATHOLOGIC FACTORS OF SPECIFIC RELAPSE TYPES IN NODE-NEGATIVE BREAST CANCER (1995) (2)
Surgical treatment of primary breast cancer according to disease extent. (1977) (2)
The effect upon mitosis in Allium cepa of an antifungal antibiotic produced by streptomyces sp. (1956) (2)
Breast cancer--trials on conservative surgery. (1995) (2)
A phase III prevention trial of low-dose tamoxifen in HRT users: The HOT trial. (2012) (2)
Surgery, radiotherapy and chemotherapy of cancer (1975) (2)
Improper use of “radioguided occult lesion localization” (ROLL) technique leads to misleading conclusions (2013) (2)
New adjuvant trials for resectable breast cancer at the Istituto Nazionale Tumori of Milan. (1984) (2)
Adjuvant treatment with prolonged CMF (CTX MTX FU) in operable breast cancer with positive axillary nodes. Progress report (1976) (2)
Breast Cancer in Childhood (1968) (2)
Cell biology and tumor immunology (1975) (2)
The evolution of cancer treatment (2012) (2)
[Surgical technic of breast amputation associated with axillary, internal mammary, supraclavicular and mediastinal lymph node excision]. (1969) (2)
[Surgery of the breast: 100 years after Halsted]. (1995) (2)
Intralymphatic administration of BCG in melanoma patients (1977) (2)
IART® (Intra-Operative Avidination for Radionuclide Therapy) for accelerated radiotherapy in breast cancer patients. Technical aspects and preliminary results of a phase II study with 90Y-labelled biotin (2010) (2)
Sentinel lymph node biopsy and intraoperative radiotherapy in breast cancer: a breakthrough? (2001) (2)
[Neoplastic transformation of cutaneous cysts; incidence, morphological aspect, pathogenesis, case reports]. (1953) (2)
Proceedings of the eleventh international cancer congress. Volume III. Cancer epidemiology, environmentals factors. Conference held at Florence, Italy, October 20--26, 1974 (1975) (2)
Full-dose intra-operative radiotherapy with electrons (ELIOT) during (2008) (2)
Alpha melanocyte stimulating hormone in human melanoma (1987) (2)
New prospects for melanoma research. (1973) (2)
New trends in breast cancer surgery. (1989) (2)
131-I accumulation in a cystoadenoma lymphomatosum of the parotid gland. (1967) (2)
[International therapeutic trial comparing the value of radical mastectomy (Halsted) and extended mastectomy (Halsted plus internal mammary node dissection in the treatment of breast cancer. 5-year results]. (1976) (2)
Researches on the etiological factors in human breast cancer. (1959) (2)
Actual data on efficacy of surgical adjuvant chemotherapy with CMF in breast cancer. (1978) (2)
Erratum to: Current Trends in the Oncologic and Surgical Managements of Breast Cancer in Women with Implants: Incidence, Diagnosis, and Treatment (2016) (2)
Local Recurrence and New Primary Ipsilateral Carcinomas After Conservative Treatment of Breast Carcinoma (1989) (2)
[6 cases of thyroid carcinoma in childhood]. (1963) (2)
Drug Delivery in Cancer Treatment II (1989) (2)
New technologies for diagnosis and treatment of breast cancer: meeting highlights from the Second Milan Breast Cancer Conference (Milan, 14–16 June 2000) (2001) (2)
Response: lymph node dissection for stage I melanoma: the unresolved dilemma. (1982) (2)
Vitamin A and retinoids: a hypothesis of tumour chemoprevention. (1984) (2)
Contribution to the Radiographical Study of Mammary Cysts with Gaseous Contrast Means (1966) (1)
Breast cancer at the end of a successful century: meeting highlights from the First Milan Breast Cancer Conference and discussion paper for the Second Conference (Milan, 14-16 June, 2000). (2000) (1)
[Intralymphatic radiotherapy in the treatment of lymph node metastases of the retroperitoneal lymphatic chain]. (1967) (1)
[Scintigraphy in the diagnosis of the nature of thyroid nodules]. (1966) (1)
9LBA Delivering safe and affordable cancer surgery to all - a Lancet Oncology Commission (2015) (1)
[Surgery limited to the breast for breast carcinoma]. (1989) (1)
[Mesenchymal malignant tumors of the thyroid]. (1969) (1)
Intraoperative radiotherapy: Rationale, techniques, results (2002) (1)
Breast Cancer (1990) (1)
1024 Axillary surgery can be avoided in selected breast cancer patients: Analysis of 401 patients (1995) (1)
The Quadrantectomy Technique for Small Breast Carcinomas. (1991) (1)
Clinical Synthesis Conference. Hormone replacement therapy (Reprinted from The Lancet, vol 354, pg 152-155, 1999) (2000) (1)
Breast Cancer (2019) (1)
7 oral: Nipple-Sparing Mastectomy with Nipple Areola Complex (NAC) Intraoperative Radiotherapy: The Five Years Experience of the European Institute of Oncology (EIO) (2009) (1)
[The use of ultrasonics in the diagnosis of neoplastic diseases]. (1967) (1)
Re: Vitamin A Analogue for Breast Cancer Prevention: a Grade of F or Incomplete? (2000) (1)
Common Goals of Prevention and Treatment of Cancer (1988) (1)
08 Sentinel node biopsy: the role of a learning phase (1999) (1)
Phase I study of 4'-epi-adriamycin (epi-ADM) (1979) (1)
Extended Radical Mastectomy with Removal of Axillary, Internal Mammary, Supraclavicular and Mediastinal Lymph Nodes (1969) (1)
[The treatment of advanced breast carcinoma with fluoxymesterone. Results of 43 personal cases]. (1961) (1)
[Anatomic-histologic features and the pathogenesis of osteocartilagenous tumors of the breast, based on eight personal observations]. (1955) (1)
Highlights of surgery and radiotherapy (2002) (1)
Malignant Mesenchymal Tumors of the Thyroid (1969) (1)
0-105. Electropotential measurements as a new modality for breast cancer diagnosis: results from a prospective multicentre trial (1997) (1)
Does tamoxifen prophylaxis for breast cancer provide long-term prevention? (2007) (1)
09 Sentinel node biopsy: the best method to stage melanoma patients for adjuvant trials (1999) (1)
Second malignancies following breast cancer treatment: a case-control study based on the Peridose methodology. Allegro project (task 5.4). (2012) (1)
Breast cancer : textbook for general practitioners (1990) (1)
Occasional notes. The management of early breast cancer. (1982) (1)
Drug Delivery in Cancer Treatment III (1990) (1)
New developments in breast cancer research (1991) (1)
Intraoperative electron-beam radiation therapy (IOERT) after conservative surgery for early stage breast cancer (2001) (1)
LYMPH-NODE IRRADIATION OF OPERABLE BREAST CANCER AND STATISTICAL POWER. AUTHOR'S REPLIE (1991) (1)
Reply to V. Arena et al (2010) (1)
The control of breast cancer: a look into the future. (1996) (1)
Proceedings XI International Cancer Congress, Florence 1974. Vol. IV: Cancer campaign, detection, rehabilitation, clinical classification (1975) (1)
Safety and efficacy of HRT and low-dose tamoxifen in a phase II trial (HOT): Analysis of mammographic density and endometrial thickness. (2011) (1)
93 P - Study on sentinel nodes in breast cancer using Lymphoscintigraphy and radio-guided probe (1996) (1)
[Italian study on the chemoprevention of breast cancer with tamoxifen]. (1995) (1)
Tamoxifen for breast cancer in hysterectomised women (2002) (1)
Plasma Cell Mastitis (1966) (0)
Adjuvant Chemotherapy of Breast Cancer: The Milan Cancer Institute Trials (1986) (0)
Surgery of Primary Melanoma (1990) (0)
The 6th Milan Breast Cancer Conference, Milan, Italy, 16–18 June 2004 (2004) (0)
Epidemiology and clinicopathological aspects of pre-malignant and malignant lesions. (1995) (0)
[Epidemiological studies in detection of environmental oncogenic risks]. (1968) (0)
Sentinel nodes scintigraphy of the internal mammary chain in breast cancer (2003) (0)
Early detection of cancer. A new branch of oncology? Diagnosi precoce dei tumori. Una nuova branca dell'oncologia? (2003) (0)
Fenretinide Breast Cancer Prevention Trial (2003) (0)
[Case reports and critical evaluation of tumors of the sympathetic nervous system]. (1953) (0)
Introduction: The Role of Surgery in Cancer Treatment (1989) (0)
Diagnosis and Staging (1990) (0)
Occult Carcinoma in Thyroid Adenoma (1966) (0)
S1 The changing concepts in treating breast cancer (1998) (0)
Erratum to: Sentinel Lymph Node Biopsy in Multicentric Breast Cancer: Five-Year Results in a Large Series from a Single Institution (2011) (0)
Nodules Detected at Baseline Computed Tomography Screening Role of Positron Emission Tomography Scanning in the Management of Lung (2013) (0)
Correlation between administered treatment and patient’s living will (2009) (0)
Quadrantectomy for malignant disease (2000) (0)
[The role of surgery in the therapeutic management of breast carcinoma]. (1980) (0)
Proceedings XI International Cancer Congress, Florence 1974. Vol. I: Cell biology and tumor immunology (1975) (0)
[Plasmacellular mastitis]. (1966) (0)
Sentinel Lymph Node Biopsy in Intraductal Carcinoma of the Breast with Microinvasion (2005) (0)
Conservative Treatment of Breast Cancer: 10-Year Follow-up in the Milan Clinical Trial (1986) (0)
Proceedings of the eleventh international cancer congress. Volume I. Cell biology and tumor immunology. Conference held at Florance, Italy, October 20--26, 1974 (1975) (0)
Continuous Arterial Infusion of 5-Fluorouracile in Patients with Advanced Breast Cancer (1967) (0)
Results of annual screening of lung cancer with low dose computed tomography in 5,000 high-risk individuals (2007) (0)
SCL1 Progress in breast cancer research and management (2000) (0)
Adjuvant Systemic Therapy (1990) (0)
Canadian Cancer Conference (1957) (0)
[Hidden foci of carcinoma in thyroid adenomas]. (1966) (0)
Erratum to: The management of ductal intraepithelial neoplasia (DIN): open controversies and guidelines of the Istituto Europeo di Oncologia (IEO), Milan, Italy (2010) (0)
S18 The axilla; To clear or not to clear? That is the question! (1998) (0)
IntraoperativeAvidination for RadionuclideTherapy : AProspective New Development toAccelerate Radiotherapy in Breast Cancer (2007) (0)
[Super-radical mastectomy: clinical results observed 3 and 5 years later]. (1978) (0)
Prognostic significance by level and number of involved nodes in 777 cases of breast cancer (1993) (0)
[Extent of surgical treatment of breast cancer depending on the spread of the tumor process]. (1977) (0)
Clinical trials in cancer medicine: Past achievements and future prospects (1985) (0)
Treatment of Overt Metastatic Disease (1990) (0)
Detection and biopsy of sentinel nodes of the internal mammary chain in breast cancer (2002) (0)
The Role of Epidemiological Investigation in the Detection of Environmental Carcinogenic Risks (1968) (0)
120 P - Chemoprevention of breast cancer: update of the Italian trial in hysterectomised women (1996) (0)
Changing concepts in breast cancer management (1998) (0)
Tumors of specific sites (1975) (0)
Professor Michael Peckham retires as editor-in-chief of the European Journal of Cancer (1995) (0)
[The female breast in senescence; histomorphological and histochemical study]. (1955) (0)
[CERVICAL METASTASES AS THE FIRST SIGN OF THYROID CARCINOMA]. (1964) (0)
SYMPOSIUM OF BREAST IMAGING Innovation in early breast cancer surgery: radio-guided occult lesion localization and sentinel node biopsy (2002) (0)
[SURGICAL TECHNIC OF EXCISION OF ISOLATED INTERNAL MAMMARY METASTASES IN PATIENTS WHO HAVE UNDERGONE RADICAL MASTECTOMY]. (1963) (0)
Erratum: Sentinel lymph node biopsy in multicentric breast cancer: Five-year results in a large series from a single institution (Annals of Surgical Oncology DOI: 10.1245/S10434-011-1694-3) (2011) (0)
316 INVITED Breast Conservation in Young Women With Early Breast Cancer (2011) (0)
Endocrine Therapy of Breast Cancer (1987) (0)
[Significance of the duration of menstrual life in the onset of breast cancer in women]. (1957) (0)
Pre operative approach to thyroid tumors by a 2 dimensional pulsed echo technique (1968) (0)
TECNICA OPERATORIA DELL'EXERESI DI METASTASI MAMMARIE INTERNE ISOLATE, IN PAZIENTI OPERATE DI MASTECTOMIA RADICALE. (1963) (0)
Scanning in the Preoperative Diagnosis of Thyroid Nodules (1966) (0)
Annals of Oncology Institution: GOT (Consortium) Sign In as Personal Subscriber (2009) (0)
RESULTS OF TREATMENT OF 2000 CONSECUTIVE CASES OF GASTRIC CARCINOMA. (1963) (0)
Abstracts exchange: European Journal of Surgical Oncology (2006) (0)
Classification of the tumors arising from the vessel-ruling tissues. (1955) (0)
Primary Hodgkin's Disease of the Thyroid (1966) (0)
Re: Vitamin A analogue for breast cancer prevention: a grade of F or incomplete? (2000) (0)
An outline on the organization of cancer control in Italy. (1974) (0)
[Benign tumors of the stomach: considerations in 27 cases]. (1958) (0)
Responses: Re: Treatment of Human Epidermal Growth Factor Receptor 2-Overexpressing Breast Cancer Xenografts With Multiagent Human Epidermal Growth Factor Receptor-Targeted Therapy (2007) (0)
Response: Lymph node dissection for stage i melanoma: the unresolved dilemma (1982) (0)
[Immunological aspects in the treatment of malignant melanoma]. (1982) (0)
Cancerization of cutaneous cysts and genesis of cylindromas. (1956) (0)
[Therapeutic and prognostic programming in cases of malignant melanoma]. (1970) (0)
[Observations on the effect of antifungal antibiotics on the root meristem of Allium cepa]. (1957) (0)
Open Access & ecancermedicalscience. (2007) (0)
Breast cancer: new trends in surgery and radiotherapy. (1989) (0)
Cancer education and training over a decade (1992) (0)
Reconstructive and Esthetic Breast Surgery (2015) (0)
Minimally invasive surgery and chemotherapy for primary breast cancer(The 105th Annual Congress of Japan Surgical Society) (2005) (0)
Melanoma guest editor (1992) (0)
Controlled study with L PAM and 5 FU (IV or PO) plus or minus prednisone in advanced breast cancer (1975) (0)
3 Surgical Techniques (2015) (0)
What is coming up in breast cancer research and treatment (1997) (0)
SS6-2 MANAGEMENT OF THE PATIENTS WITH BREAST CANCER BY SENTINEL NODE NAVIGATION SURGERY (2000) (0)
Ricordo Di Aldo Perussia (1987) (0)
Open Access & ecancermedicalscience (2007) (0)
A drug for perioperative therapy in two steps of solid tumors (2004) (0)
The quality of surgery as a prerequisite for breast conservation (1993) (0)
[Chemotherapy of malignant melanoma]. (1973) (0)
[The role of surgery in the treatment of breast cancer]. (1968) (0)
[Indications and preliminary results of diagnostic laparotomy in various types of malignant lymphoma]. (1971) (0)
[Problem of cancer heredity in man. 3. Cancer of the uterus]. (1956) (0)
[Clinical and histomorphological considerations on 230 cases of mammary secretion]. (1959) (0)
Proceedings XI International Cancer Congress, Florence 1974. Vol. II: Chemical and viral oncogenesis (1975) (0)
[Primary malignant lymphogranuloma of the thyroid gland]. (1966) (0)
S32 Integrated therapies for the next decade: A vision for the future (2011) (0)
Meme koruyucu cerrahide i̇ntraoperatif elektron radyoterapisi, ELIOT: "European Institute of Oncology" randomize çalişmasi (2003) (0)
[Epidemiology, etiological factors and histological classification of malignant tumors of the thyroid]. (1971) (0)
Genetical Variation in Human Populations (1962) (0)
Biological Factors Affecting the Prognosis and Treatment of Cancer (1967) (0)
[Histological profile, pathogenesis and nosological picture in giant-cell epulis; 118 personal case reports]. (1954) (0)
Innovation in care and research: meeting highlights from the seventh Milan Breast Cancer Conference (Milan, 15-17 June, 2005). (2006) (0)
Chemical and viral oncogenesis (1975) (0)
The role of intra-operative radiotherapy (IORT) in the conservative management of early-stage breast cancer (2005) (0)
S34 Targeting the tumour and sparing normal tissue: The concept behind the evolution (2009) (0)
Comment on: Treatment of Human Epidermal Growth Factor Receptor 2-Overexpressing Breast Cancer Xenografts With Multiagent Human Epidermal Growth Factor Receptor-Targeted Therapy. Authors' reply (2007) (0)
Lymphohaematopoietic Growth Factors in Cancer Therapy II (1992) (0)
Proceedings XI International Cancer Congress, Florence 1974. Vol. III: Cancer epidemiology, environmental factors (1975) (0)
Paradigm Changes in Medical Science (2008) (0)
[Research on the antimitotic activity of a new actinomycin]. (1955) (0)
[Effect of podophyllin and of podophyllotoxin on blood picture in rat]. (1952) (0)
Proceedings XI International Cancer Congress, Florence 1974. Vol. V: Surgery, Radiotherapy and Chemotherapy of Cancer (1975) (0)
The local treatment of elderly women with breast cancer (2004) (0)
The European Institute of Oncology in Milan (2006) (0)
Le traitement du cancer du sein en 1988 (1989) (0)
Epidemiology of Breast Cancer (1990) (0)
Myth #1: The Healthcare System Is Failing (2018) (0)
Surgical Procedure in the Exeresis of Solitary Internal Mammary Metastases (1963) (0)
« Radiation Biology and Cancer » (1959) (0)
The Surgery of Malignant Disease (1914) (0)
8 poster FOUR YEAR RESULTS OF ELECTRON INTRAOPERATIVE BOOST AND HYPOFRACTIONATED EXTERNAL BEAM RADIOTHERAPY AFTER BREAST-CONSERVING SURGERY IN PREMENOPAUSAL WOMEN (2011) (0)
Treatment of ductal carcinoma in situ of the breast: results from a monoinstitutional cohort of 1308 women (2007) (0)
P33 A comparative study on the value of FDG-PET & SNB to identify axillary metastases (2007) (0)
Breast Cancer in Women with Cystic Disease of the Breast (1965) (0)
Key questions on breast cancer (1990) (0)
History of the last 100 years of attempts to control neoplastic disease. (1985) (0)
[Consequences of the bioptic removal in neoplasms of the larynx]. (1990) (0)
[Continuous infusion of 5-fluorouracil in advanced mammary carcinoma]. (1967) (0)
Histogenesis of Paget's disease of the nipple; a report of 20 cases. (1955) (0)
Results of Endolymphatic Radiotherapy: Histological Aspects (1971) (0)
High dose surgery — The more the better? (1999) (0)
Abstract B3: A nested case control study of the polymorphic locus -202 in the promoter region of the IGFBP-3 gene and breast cancer risk (2010) (0)
[Conservative surgery of breast carcinoma of small dimensions]. (1982) (0)
Lymphocyte blastic transformation and DNCB response after thymectomy in man. (1974) (0)
Cancer of the breast (1962) (0)
Cancer campaigns, detection, rehabilitation, clinical classification (1975) (0)
Proceedings XI International Cancer Congress; Florence Vol XI: Tumors of specific sites (1975) (0)
THE NEW POSSIBILITIES OF PREDICTION AND PREVENTION OF CANCER (2013) (0)
Malignant: Evaluation of the risk of primary multiple melanoma in cutaneous malignant melanoma. (Italian) (1978) (0)
Control of Growth Factors and Prevention of Cancer (1992) (0)
Second Malignancies following Breast Cancer Treatment: A Case-Control Study Based on the Peridose Methodology. ALLEGRO Project (Task 5.4) (2012) (0)
Radioguided sentinel node biopsy : a historical milestone in breast cancer treatment (2002) (0)
[Therapeutic planning and prognosis in cutaneous malignant melanoma]. (1969) (0)
Paradigm changes in medical science. (2008) (0)
Intraoperative radiotherapy with electrons (ELIOT) to the breast (2003) (0)
Photograph Illus. 11.1 (2016) (0)
Regional Lymph Node Metastases in the Prognosis of Melanoma (1969) (0)
Thyroid Carcinoma in Childhood: Report of Six Cases (1963) (0)
[Cytological diagnosis of Paget's disease of the nipple]. (1954) (0)
Abstract A71: 4-HPR trial: A new phase III chemoprevention trial with fenretinide in high-risk women. Rationale, design and implementation (2010) (0)
Sentinel node in colon cancer (2009) (0)
Treatment of breast cancer. (2000) (0)
Incidenza del cancro mammario in donne affette da mastopatia cistica. (1965) (0)
Initial results of a phase III study show safety of HRT and low dose tamoxifen. (2016) (0)
Treatment: General Strategy (1990) (0)
Atlas of Breast Surgery (2015) (0)
Operationen am Ösophagus (1954) (0)
Variables in the axilla: New prognostic factors in N+ breast cancer analysis of 1003 cases (1994) (0)
Breast Cancer and Intra-operative Radiotherapy with Electrons at the European Institute of Oncology (2007) (0)
[Antimitotic activity of a new actinomycin preparation in vitro chick embryo fibroblast culture]. (1955) (0)

This paper list is powered by the following services:

Umberto Veronesi's Academic­Influence.com Rankings

Umberto Veronesi's Degrees

Why Is Umberto Veronesi Influential?

Umberto Veronesi's Published Works

Published Works

Umberto Veronesi's AcademicInfluence.com Rankings